Flow-cytometric quantitation in chronic leukemias

European Journal of Histochemistry

Volumn 40, Issue SUPPL.1, 1996, Pages 33-38

  Lavabre Bertrand, T ^a  

^a LAPEYRONIE HOSPITAL   (France)

Author keywords

Chronic lymphocytic leukemia; Immune phenotype; Immune quantitation; Non Hodgkin's lymphoma

Indexed keywords

CHRONIC DISEASE; DIFFERENTIAL DIAGNOSIS; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; IMMUNOPHENOTYPING; LEUKEMIA; METHODOLOGY; PATHOLOGY; REVIEW;

CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FLOW CYTOMETRY; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA;

EID: 0029682996     PISSN: 1121760X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Abe M., Tominaga K., and Wakasa H.: Phenotypic characterization of human B-lymphocyte subpopulations, particularly human CD5+ B-lymphocyte subpopulation within the mantle zones of secondary follicles. Leukemia 8, 1039-1044, 1994
2. Almasri N.M., Duque R.E., Iturraspe J.I., Everett E., and Braylan R.C.: Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia. Am .J. Hematol. 40, 259-263, 1992
3. Barnett D., and Reilly J.T.: Lack of correlation between cell surface activation antigen expression and clinical stage in B-CLL. Br. J. Haematol. 73, 572, 1989
4. Batata A., and Shen B.: Immunophenotyping of subtypes of B-chronic (mature) lymphoid leukemia. Cancer 70, 2436-2443, 1992
5. Begleiter A., Lee K., Israels L.G., Mowat M.R.A., and Johnston J.B.: Chlorambucil induced apoptosis in chronic lymphocytic leukemia (CLL) and its relationship to clinical efficacity. Leukemia Suppl 1, S103-106, 1994
6. Benett J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R., and Sultan C.: The French-American-British (FAB) Cooperative group. Proposals for the classification of chronic (mature) B and T lymphoid leukemias. J. Clin. Pathol. 42, 567-584, 1989
7. Bhat N.M., Kantor A.B., Bieber M.M., Stall A.M., Herzenberg L.A., and Teng N.N.: The ontogeny and functional characteristics of human B-1 (CD5+ B) cells. Int. Immunol. 4, 243-252, 1992
8. Bushle M., Campana D., Carding S.R., Richard C., Hoffbrand A.V., and Brenner M.K.: Interferon γ inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 177, 213-218, 1993
9. Caldwell C.W., and Patterson W.P.: Relationship between CD45 antigen expression and putative stages of differentiation in B-cell malignancies. Am. J. Hematol. 36, 111-115, 1991
10. Carbonari M., Cibati M., Cherchi M., Sbarigia D., Pesce A.M., Dell'Anna L., Modica A., and Fiorili M.: Detection and characterization of apoptotic peripheral blood lymphocytes in human immunodeficiency virus infection and cancer chemotherapy by a novel immunocytometric method. Blood 83, 1268-1277, 1994
11. Casellas P., Canat X., Fauser A., Gros O., Laurent G., and Poncelet P.: Optimal elimination of leukemic T cells from human bone marrow with T101-ricin-A- chain immunotoxin. Blood 65, 289-297, 1985
12. Catovsky D., Cherchi M., Brooks D., Bredley J., and Zola H.: Heterogeneity of B cell leukemia demonstrated by the monoclonal antibody FMC7. Blood 58, 406-408, 1981
13. Catovsky D., and Matutes E.: The classification of lymphoid leukaemias. Leuk. Lymphoma suppl, 153-155, 1991
14. Collins J.R., Verschuer L.A., Harmon B.V., Prentice R.L., Pope J.H., and Kerr J.F.: Spontaneous programmed cell death (apoptosis) of B-chronic lymphocytic leukemia cells following their culture in vitro. Br. J. Haematol. 71, 343, 1989
15. Cory S.: Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13, 513-543, 1995
16. Dadmarz R., and Cawley J.C.: Heterogeneity of CLL: High CD23 antigen and a-IFN receptor expression are features of favourable disease and of cell activation. Br. J. Haematol. 68, 279-282, 1988
17. De Rossi G., Tenca C., Cerruti G., Favre A., Zarcone D., Tabilio A., Mauro, .R., Annino L., and Grossi C.E.: Adhesion molecule expression on B-cells from acute and chronic lymphoid leukemias. Leuk. Lymphoma 16, 31-36, 1994
18. Dorken B., Moller P., Pezzutto R., Schwartz-Albiez R., and Moldenhauer G.: B cell antigens: CD24. W. Knapp. Leucocyte Typing IV. Oxford University Press. Oxford. 1989. 82-83
19. Gale R.P., and Foon K.A.: Biology of chronic lymphocytic leukemia. Semin. Hematol. 24, 209-229, 1987
20. Gee A.P., Mansour V.H., and Weiler M.B.: Effects of target antigen density on the efficacy of immunomagnetic cell separation. J. Immunol. Methods 142, 127-136, 1991
21. Geisler C.H., Larsen J.K., Hansen N.E., Hansen M.M., Christensen B.E., Lund B., Nielsen H., Plesner T., Thorling K., Andersen E., and Andersen P.K.: Prognostic importance of flow cytometry immunophenotyping of 540 consecutive patients with B-cell lymphocytic leukemia. Blood 78, 1795-1802, 1991
22. Gibson J., Neville S., Joshua D., and Kroninberg H.: CD23 antigen expression in CLL. Br. J. Haematol. 72, 598, 1989
23. Harris N.L., Jaffe E.S., Stein H., Banks P.M., Chan J.K.C., Cleary M.L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K.C., Grogan T.M., Isaacson P.O., Knowles D.M., Mason D.Y., Muller-Hermelink H.K., Pileri S., Piris M.A., Ralfkiaer E., and Warnke R.A.: A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood 84, 1361-1392, 1994
24. Jewell A.P., Yong K.L., Worman C.P., Giles F.J., Goldstone A.H., and Lydyard P.M.: Cytokine induction of leucocyte adhesion molecule-1 (LAM-1) expression on chronic lymphocytic leukemia cells. Leukemia 6, 400-404, 1992
25. Jewell A.P., Worman C.P., Lydyard P.M., Yong K.L., Giles F.J., and Goldstone A.H.: Interferon-alpha up-regulates bcl-2 expression and protects B-CLL cells from apoptosis in vitro and in vivo. Br. J. Haematol. 88, 268-274, 1994
26. Kimby E., Mellstedt H., Björkholm M., and Holm G.: Clonal cell surface structures related to differentiation, activation, and homing in B-cell chronic lymphocytic leukaemia and monoclonal lymphocytosis of unknown significance. Eur. J. Haematol. 43, 452-459, 1989
27. Kipps T.J.: The CD5 B cell. Adv. Immunol. 47 117-185, 1989
28. Kishimoto H., Surh C.D., and Sprent J.: Upregulation of surface markers on dying thymocytes. J. Exp. Med. 181, 649-655, 1995
29. Kurec A.S., Threatte G.A., Gottlieb A.J., Smith J.R., Anderson J., and Davey F.R.: Immunophenotypic subclassification of chronic lymphocytic leukemia (CLL). Br. J. Haematol. 81, 45-51, 1992
30. Lavabre-Bertrand T., Duperray C., Brunet C., Poncelet P., Exbrayat C., Bourquard P., Lavabre-Bertrand C., Brochier J., Navarro M., and Janossy G.: Quantification of CD24 and CD45 antigens in parallel allows a precise determination of B cell maturation stages. Relevance for the study of B cell neoplasias. Leukemia 8, 402-408, 1994a
31. Lavabre-Bertrand T., Exbrayat C., Bourquard P., Lavabre-Bertrand C., Fégueux N., Poncelet P., Rousset T., Taïb J., Emberger J.M., and Navarro M.: CD23 antigen density is related to serum gamma globulin level, bone marrow reticulin pattern and treatment in B chronic lymphocytic leukemia. Leuk. Lymphoma 13, 89-94, 1994b
32. Lavabre-Bertrand T., George F., Brunet C., and Sampol J.: Quantitative immune phenotyping: a new dimension for the monitoring of haemopoietic malignancies. Nouv. Rev. Fr. Hematol. 36, 373-382, 1994c
33. Lavabre-Bertrand T., Janossy G., Exbrayat C., Bourquard P., Duperray C., and Navarro M.: Leukemia associated changes identified by quantitative flow cytometry. II. CD5 over-expression and monitoring in B-CLL. Leukemia 8, 1557-1563, 1994d
34. LeBien T.W., Wormann B., Villablanca J.G., Law C.L., Steinberg L.M., Shah V.O., and Loken M.R.: Multiparameter flow cytometric analysis of human fetal bone marrow B cells. Leukemia 4, 354-358, 1990
35. Legac E., Chastang C., Binet J.L., Michel A., Debré P., and Merle-Béral H.: Proposals for a phenotypic classification of B-chronic lymphocylic leukemia, relationship with prognostic factors. Leuk. Lymphoma suppl, 53-58, 1991
36. Mapara M.K., Bargou R., Zugck C., Döhner H., Ustaoglu F., Jonker R.R., Krammer P.H., and Dörken B.: APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur. J. Immunol. 23, 702-708, 1993
37. Mariano M.T., Moretti L., Donelli A., Grantini M., Montagnani G., Di Frisco A.U., Torelli G., Torelli U., and Narni F.: bcl-2 gene expression in hematopoietic cell differentiation. Blood 80, 768-775, 1992
38. Marti G.E., Faguet G., Berlin P., Agee J., Washington G., Ruiz S., Cater P., Zenger V., Vogt R., and Noguchi P.: CD20 and CD5 expression in B-chronic lymphocytic leukemia. Ann. NY Acad. Sci. 651, 480-483, 1992
39. Matutes E., and Catovsky D.: The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders. Leuk. Lymphoma 13 suppl 1, 11-14, 1994
40. Newman R.A., Peterson B., Davey F.R., Brabyn C., Collins H., Brunetto V.L., Duggan D.B., Weiss R.B., Royston I., Millard F.E., Miller A.A., and Bloomfield C.D.: Phenotypic markers and BCL-1 gene rearrangements in B-cell chronic lymphocytic leukemia: a cancer and leukemia group B study. Blood 82, 1239-1246, 1993
41. Panayiotidis P., Ganeshaguru K., Jabbar S.A.B., and Hoffbrand V.A.: Interleukin-4 inhibits apoptotic cell death and loss of the bcl-2 protein in B-chronic lymphocytic leukaemia cells in vitro. Br. J. Haematol. 85, 439-445, 1993
42. Panayiotidis P., Ganeshaguru K., Jabbar S.A.B., and Hoffbrand A.V.: Alpha-interferon (a-IFN) protects B-chronic lymphocytic leukaemia cells from apoptotic cell death in vitro. Br. J. Haematol. 86, 169-173, 1994
43. Peters R.E., Janossy G., Ivory K., al-Ismail S., and Mercolino T.: Leukemia-associated changes identified by quantitative flow cytometry. III. B-cell gating in CD37/ kappa/lambda clonality test. Leukemia 8, 1864-1870, 1994
44. Petit P.X., Lecoeur H., Zorn E., Dauguet C., Mignotte B., and Gougeon M.L.: Alterations in mitochondrial structures and function are early events of dexamethasone-induced thymocyte apoptosis. J. Cell. Biol. 130, 157-167, 1995
45. Poncelet P., Brunet C., George F., Bikoue A., and Sampol J.: Influence of target antigen density on the efficacy of immuno-magnetic separation (IMS) of cells. John Ugelstadt Conference, Oxford, April 1991, 1991
46. Robbins B.A., Ellison D.J., Spinosa J.C., Carey C.A., Lukes R.J., Poppema S., Saven A., and Piro L.D., 1277-87, Blood. 1993 Aug 15; 82(4):. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 82, 1277-1287, 1993
47. Robbins B.A., Ellison D.J., Spinosa J.C., Carey C.A., Lukes R.J., Poppema S., Saven A., and Piro L.D., 1277-87, Blood. 1993 Aug 15; 82(4):. Diagnostic application of two-color flow cytometry in 161 cases of hairy cell leukemia. Blood 82, 1277-1287, 1993
48. Shah V.O., Civin C.I., and Loken M.R.: Flow cytometric analysis of human bone marrow. IV. Differential expression of T-200 common leukocyte antigen during normal hemopoiesis. J. Immunol. 140 1861-1867, 1988
49. Ternynck T., Dighiero G., Follezou J.Y., and Binet J.L.: Comparison of normal and CLL lymphocytes surface Ig determinants using peroxidase labelled antibodies. I. Detection and quantitation of light chain determinants. Blood 43, 789-795, 1974
50. Uckun F.M.: Regulation of human B cell ontogeny. Blood 76, 1908-1923, 1990
51. Vuillier R, Claisse J.F., Vandenvelde C., Travade P., Magnac C., Chevret S., Desablens, B., Binet J.L., and Dighiero G.: Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients in clinical and bone-marrow remission using CD5-CD19 markers and PCR study of gene rearrangements. Leuk. Lymphoma 7, 195-204, 1992
52. Witzig T.E., Borell T.J., Herath J.F., Tefferi A., Li C.Y., and Jenkins R.B.: Detection of trisomy 12 by FISH in untreated B-chronic lymphocytic leukemia: correlation with stage and CD20 antigen expression intensity. Leuk. Lymphoma 14, 447-451, 1994
53. Wulf G., Kluding H., Ho A.D., Doerner M., Doehner H., Manegold C., and Hunstein W.: Multidrug resistance phenotype in patients with chronic lymphocytic leukemia as detected by immunofluorescence (FACS) and northern blot analysis. Leuk. Res. 18, 475-484, 1994
54. Yoshino T., Kondo E., Cao L., Takahashi K., Hayashi K., Nomura S., and Akagi T.: Inverse expression of bcl-2 protein and Fas antigen in lymphoblasts in peripheral lymph nodes and activated peripheral blood T and B lymphocytes. Blood 83, 1856-1861, 1994
55. Zamzami N., Marchetti P., Castedo M., Zanin C., Vayssière J.L., Petit P.X., and Kroemer G.: Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocytes death in vivo. J. Exp. Med. 181, 1661-1672, 1995
56. Zinzani P.L., Tosi P., Visani G., Martinelli G., Farabegoli P., Buzzi M., Ottaviani E., Salvucci M., Bendandi M., Zaccaria A., and Tura S.: Apoptosis induction with three nucleoside analogs on freshly isolated B-chronic lymphocytic leukemia cells. Am. J. Hematol. 47, 301-306, 1994